| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.32 | 2e-12 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-07 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-07 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.25 | 6e-06 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-05 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-05 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.24 | 0.0001 |